MSM 707
Alternative Names: MSM-707Latest Information Update: 06 Sep 2023
At a glance
- Originator MSM Protein Technologies
- Class Antibodies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Graft-versus-host disease
Most Recent Events
- 06 Sep 2023 MSM 707 is still in preclinical trials for Graft-versus-host disease in USA (MSM Protein Technologies website, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Graft-versus-host-disease in USA
- 15 Jul 2016 MSM 707 is available for licensing -http://msmprotein.com/about/